Published in Health Business Week, June 30th, 2006
L.F. Zhou and colleagues, Nanjing Medical University, wrote that the study was done "to investigate the effects of adenoviral gene transfer of I kappa B alpha mutant (I kappa B alpha M), a novel inhibitor of nuclear factor kappa B (NF-kappa B), on apoptosis, phenotype and function of human monocyte-derived dendritic cells (DC)."
The researchers explained, "Monocytes were cocultured with granulocyte/macrophage...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.